120 related articles for article (PubMed ID: 25350151)
1. An in vitro model for the study of cellular pathophysiology in globoid cell leukodystrophy.
Claycomb KI; Johnson KM; Bongarzone ER; Crocker SJ
J Vis Exp; 2014 Oct; (92):e51903. PubMed ID: 25350151
[TBL] [Abstract][Full Text] [Related]
2. MMP-3 mediates psychosine-induced globoid cell formation: implications for leukodystrophy pathology.
Ijichi K; Brown GD; Moore CS; Lee JP; Winokur PN; Pagarigan R; Snyder EY; Bongarzone ER; Crocker SJ
Glia; 2013 May; 61(5):765-77. PubMed ID: 23404611
[TBL] [Abstract][Full Text] [Related]
3. A microglial hypothesis of globoid cell leukodystrophy pathology.
Nicaise AM; Bongarzone ER; Crocker SJ
J Neurosci Res; 2016 Nov; 94(11):1049-61. PubMed ID: 27638591
[TBL] [Abstract][Full Text] [Related]
4. Aberrant production of tenascin-C in globoid cell leukodystrophy alters psychosine-induced microglial functions.
Claycomb KI; Winokur PN; Johnson KM; Nicaise AM; Giampetruzzi AW; Sacino AV; Snyder EY; Barbarese E; Bongarzone ER; Crocker SJ
J Neuropathol Exp Neurol; 2014 Oct; 73(10):964-74. PubMed ID: 25192051
[TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
6. Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy.
Snook ER; Fisher-Perkins JM; Sansing HA; Lee KM; Alvarez X; MacLean AG; Peterson KE; Lackner AA; Bunnell BA
Am J Pathol; 2014 Feb; 184(2):382-96. PubMed ID: 24316110
[TBL] [Abstract][Full Text] [Related]
7. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model.
Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL
Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749
[TBL] [Abstract][Full Text] [Related]
8. Murine globoid cell leukodystrophy (the twitcher mouse). The presence of characteristic inclusions in the kidney and lymph nodes.
Takahashi H; Igisu H; Suzuki K; Suzuki K
Am J Pathol; 1983 Aug; 112(2):147-54. PubMed ID: 6309008
[TBL] [Abstract][Full Text] [Related]
9. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and pathological evaluation of long-lived mice with globoid cell leukodystrophy after bone marrow transplantation.
Luzi P; Rafi MA; Zaka M; Rao HZ; Curtis M; Vanier MT; Wenger DA
Mol Genet Metab; 2005; 86(1-2):150-9. PubMed ID: 16169269
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of mouse embryonic stem cell-derived oligodendrocytes in the murine model of globoid cell leukodystrophy.
Kuai XL; Ni RZ; Zhou GX; Mao ZB; Zhang JF; Yi N; Liu ZX; Shao N; Ni WK; Wang ZW
Stem Cell Res Ther; 2015 Mar; 6(1):30. PubMed ID: 25888852
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid and serum glycosphingolipid biomarkers in canine globoid cell leukodystrophy (Krabbe Disease).
Corado CR; Pinkstaff J; Jiang X; Galban EM; Fisher SJ; Scholler O; Russell C; Bagel JH; ODonnell PA; Ory DS; Vite CH; Bradbury AM
Mol Cell Neurosci; 2020 Jan; 102():103451. PubMed ID: 31794880
[TBL] [Abstract][Full Text] [Related]
13. Murine model of genetic demyelinating disease: the twitcher mouse.
Suzuki K; Taniike M
Microsc Res Tech; 1995 Oct; 32(3):204-14. PubMed ID: 8527855
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
15. Identification of a molecular target of psychosine and its role in globoid cell formation.
Im DS; Heise CE; Nguyen T; O'Dowd BF; Lynch KR
J Cell Biol; 2001 Apr; 153(2):429-34. PubMed ID: 11309421
[TBL] [Abstract][Full Text] [Related]
16. Immunological considerations for treating globoid cell leukodystrophy.
Karumuthil-Melethil S; Gray SJ
J Neurosci Res; 2016 Nov; 94(11):1349-58. PubMed ID: 27638617
[TBL] [Abstract][Full Text] [Related]
17. Globoid cell leukodystrophy: specialized contact of globoid cell with astrocyte in the brain of twitcher mouse.
Takahashi H; Suzuki K
Acta Neuropathol; 1982; 58(4):237-42. PubMed ID: 6297224
[TBL] [Abstract][Full Text] [Related]
18. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
[TBL] [Abstract][Full Text] [Related]
19. Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy.
Matsushima GK; Taniike M; Glimcher LH; Grusby MJ; Frelinger JA; Suzuki K; Ting JP
Cell; 1994 Aug; 78(4):645-56. PubMed ID: 8069913
[TBL] [Abstract][Full Text] [Related]
20. Characteristic inclusions in the kidney of canine globoid cell leukodystrophy.
Suzuki K
Acta Neuropathol; 1986; 69(1-2):33-7. PubMed ID: 3008490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
